Wave Life Sciences Director Executes Major Stock Sale
Adrian Rawcliffe, a director at Wave Life Sciences, sold 42,000 shares for approximately $630,000 on December 8, 2025, through an exercise-and-sell transaction under a prearranged trading plan.
Topic
Latest reporting and analysis tagged with Wave Life Sciences.
Adrian Rawcliffe, a director at Wave Life Sciences, sold 42,000 shares for approximately $630,000 on December 8, 2025, through an exercise-and-sell transaction under a prearranged trading plan.